Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID)
NCT01515774
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Parkinson's Disease
Interventions
DRUG:
Mirapex ER
Sponsor
Seoul National University Hospital